Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.

Nyilas, Sylvia Meryl; Schreder, Theresa; Singer, Florian; Pöllinger, Alexander; Geiser, Thomas; Latzin, Philipp; Funke-Chambour, Manuela (2018). Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis. Respirology, 23(8), pp. 764-770. Wiley 10.1111/resp.13294

	Text Multiple breath washout_A new and promising lung function test for patients with idiopathic pulmonary fibrosis_Nyilas.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (398kB) | Request a copy
	Text Nyilas_et_al-2018-Respirology.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (374kB) | Request a copy

BACKGROUND AND OBJECTIVE

Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple-breath washout (N -MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N -MBW in IPF.

METHODS

In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N -MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DL ), bronchiectasis score from computed tomography scans, the Gender-Age-Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage.

RESULTS

All patients were able to perform N -MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1-13.8) in IPF versus 7.3 (6.9-8.4) in controls (P < 0.0001). LCI correlated with DL corrected for haemoglobin (corrDL ; r = -0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow-up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population.

CONCLUSION

N -MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality.

Interest & Impact

Downloads

4 since deposited on 16 Jul 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item